Technical indicators show Insmed stock poised to gain 30% from current levels.
Detailed price information for Pfizer Inc (PFE-N) from The Globe and Mail including charting and trades.
Analysts downgraded UWMC, ACT, ROIV, INSM; ACT’s target fell to $44.
Insmed Incorporated announced that Chief Financial Officer Sara Bonstein will step down after the company reported its third-quarter 2026 results and reaffirmed its full-year 2026 revenue guidance for BRINSUPRI® (brensocatib) of US$1.25 billion to US$1.40 billion and for ARIKAYCE® of US$450 million to US$470 million. The combination of a planned CFO transition and reiterated product revenue guidance offers investors a clearer view of Insmed’s operational continuity during an important...
Detailed price information for Insmed Inc (INSM-Q) from The Globe and Mail including charting and trades.
Insmed (NASDAQ:INSM) has outperformed the market over the past 5 years by 17.45% on an annualized basis producing an average annual return of 29.54%. Currently, Insmed has a market capitalization of $22.80 billion.
This is the newest page. Registered accounts read further back.